The recent discontinuation of commercially available acyclovir oral suspension is expected to create an unmet need for a vital medication.


Given the absence of an acyclovir suspension formula with appropriate stability data, PCCA is providing the Valacyclovir oral suspension formulation as an alternative medication option.


Valacyclovir 50 mg/mL Oral Suspension (Anhydrous SuspendIt®), formula uses the commercially available drug product, Valacyclovir, and provides a 180-day BUD studied with a stability-indicating assay.

Get the Formula

Complete the form*, and you will immediately receive an email with a link to download the Valacyclovir 50 mg/mL Oral Suspension formula and stability report.

*Your contact information will not be used for future marketing purposes. 

Contact PCCA with questions regarding acquiring the Anhydrous SuspendIt oral suspension base or PCCA membership by emailing [email protected] or call 800.668.9453.

Looking for a pharmacy to compound this medication? Visit Find A Compounder.

Additional Resources